Envoy Medical, Inc. (COCH): Valuation
TTM figures as of June 30, 2026
Envoy Medical, Inc. trades at a -38.00% free-cash-flow yield. That FCF yield is higher than 64% of its own month-end history back to 2022.
Earnings yield -40.97%. Shareholder yield -52.88%. Piotroski F-score 4 of 9.
48 month-end valuation observations are on file, starting September 2022.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is COCH cheap versus its own history?
Envoy Medical, Inc. trades at a -38.00% free-cash-flow yield. That FCF yield is higher than 64% of its own month-end history back to 2022.
What is COCH's free-cash-flow yield?
Envoy Medical, Inc. currently yields -38.00% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.